Global Companion Diagnostics Market Growth (Status and Outlook) 2023-2029

February 2023 | 103 pages | ID: G2417096233EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Companion Diagnostics Industry Forecast” looks at past sales and reviews total world Companion Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Companion Diagnostics sales for 2023 through 2029. With Companion Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Companion Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Companion Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Companion Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Companion Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Companion Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Companion Diagnostics.

The global Companion Diagnostics market size is projected to grow from US$ 3885.5 million in 2022 to US$ 9547 million in 2029; it is expected to grow at a CAGR of 13.7% from 2023 to 2029.

United States market for Companion Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Companion Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Companion Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Companion Diagnostics players cover Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Life Technologies, GE Healthcare, Agendia, Qiagen and Genomic Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Companion Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Polymerase Chain Reaction (PCR)
• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Next Generation Sequencing (NGS)

Segmentation by application

• Hospitals
• Pharmaceutical Companies
• Laboratories
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche Holdings
• Abbott Laboratories
• Thermo Fisher Scientific
• Agilent Technologies
• Life Technologies
• GE Healthcare
• Agendia
• Qiagen
• Genomic Health
• Myriad Genetics
• Advanced Cell Diagnostics
• Danaher
• Applied Proteomics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Companion Diagnostics Market Size 2018-2029
  2.1.2 Companion Diagnostics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Companion Diagnostics Segment by Type
  2.2.1 Polymerase Chain Reaction (PCR)
  2.2.2 Immunohistochemistry (IHC)
  2.2.3 In Situ Hybridization (ISH)
  2.2.4 Next Generation Sequencing (NGS)
2.3 Companion Diagnostics Market Size by Type
  2.3.1 Companion Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Companion Diagnostics Market Size Market Share by Type (2018-2023)
2.4 Companion Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Pharmaceutical Companies
  2.4.3 Laboratories
  2.4.4 Other
2.5 Companion Diagnostics Market Size by Application
  2.5.1 Companion Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Companion Diagnostics Market Size Market Share by Application (2018-2023)

3 COMPANION DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Companion Diagnostics Market Size Market Share by Players
  3.1.1 Global Companion Diagnostics Revenue by Players (2018-2023)
  3.1.2 Global Companion Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Companion Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COMPANION DIAGNOSTICS BY REGIONS

4.1 Companion Diagnostics Market Size by Regions (2018-2023)
4.2 Americas Companion Diagnostics Market Size Growth (2018-2023)
4.3 APAC Companion Diagnostics Market Size Growth (2018-2023)
4.4 Europe Companion Diagnostics Market Size Growth (2018-2023)
4.5 Middle East & Africa Companion Diagnostics Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Companion Diagnostics Market Size by Country (2018-2023)
5.2 Americas Companion Diagnostics Market Size by Type (2018-2023)
5.3 Americas Companion Diagnostics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Companion Diagnostics Market Size by Region (2018-2023)
6.2 APAC Companion Diagnostics Market Size by Type (2018-2023)
6.3 APAC Companion Diagnostics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Companion Diagnostics by Country (2018-2023)
7.2 Europe Companion Diagnostics Market Size by Type (2018-2023)
7.3 Europe Companion Diagnostics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Companion Diagnostics by Region (2018-2023)
8.2 Middle East & Africa Companion Diagnostics Market Size by Type (2018-2023)
8.3 Middle East & Africa Companion Diagnostics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST

10.1 Global Companion Diagnostics Forecast by Regions (2024-2029)
  10.1.1 Global Companion Diagnostics Forecast by Regions (2024-2029)
  10.1.2 Americas Companion Diagnostics Forecast
  10.1.3 APAC Companion Diagnostics Forecast
  10.1.4 Europe Companion Diagnostics Forecast
  10.1.5 Middle East & Africa Companion Diagnostics Forecast
10.2 Americas Companion Diagnostics Forecast by Country (2024-2029)
  10.2.1 United States Companion Diagnostics Market Forecast
  10.2.2 Canada Companion Diagnostics Market Forecast
  10.2.3 Mexico Companion Diagnostics Market Forecast
  10.2.4 Brazil Companion Diagnostics Market Forecast
10.3 APAC Companion Diagnostics Forecast by Region (2024-2029)
  10.3.1 China Companion Diagnostics Market Forecast
  10.3.2 Japan Companion Diagnostics Market Forecast
  10.3.3 Korea Companion Diagnostics Market Forecast
  10.3.4 Southeast Asia Companion Diagnostics Market Forecast
  10.3.5 India Companion Diagnostics Market Forecast
  10.3.6 Australia Companion Diagnostics Market Forecast
10.4 Europe Companion Diagnostics Forecast by Country (2024-2029)
  10.4.1 Germany Companion Diagnostics Market Forecast
  10.4.2 France Companion Diagnostics Market Forecast
  10.4.3 UK Companion Diagnostics Market Forecast
  10.4.4 Italy Companion Diagnostics Market Forecast
  10.4.5 Russia Companion Diagnostics Market Forecast
10.5 Middle East & Africa Companion Diagnostics Forecast by Region (2024-2029)
  10.5.1 Egypt Companion Diagnostics Market Forecast
  10.5.2 South Africa Companion Diagnostics Market Forecast
  10.5.3 Israel Companion Diagnostics Market Forecast
  10.5.4 Turkey Companion Diagnostics Market Forecast
  10.5.5 GCC Countries Companion Diagnostics Market Forecast
10.6 Global Companion Diagnostics Forecast by Type (2024-2029)
10.7 Global Companion Diagnostics Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Roche Holdings
  11.1.1 Roche Holdings Company Information
  11.1.2 Roche Holdings Companion Diagnostics Product Offered
  11.1.3 Roche Holdings Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Roche Holdings Main Business Overview
  11.1.5 Roche Holdings Latest Developments
11.2 Abbott Laboratories
  11.2.1 Abbott Laboratories Company Information
  11.2.2 Abbott Laboratories Companion Diagnostics Product Offered
  11.2.3 Abbott Laboratories Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Abbott Laboratories Main Business Overview
  11.2.5 Abbott Laboratories Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific Companion Diagnostics Product Offered
  11.3.3 Thermo Fisher Scientific Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Agilent Technologies
  11.4.1 Agilent Technologies Company Information
  11.4.2 Agilent Technologies Companion Diagnostics Product Offered
  11.4.3 Agilent Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Agilent Technologies Main Business Overview
  11.4.5 Agilent Technologies Latest Developments
11.5 Life Technologies
  11.5.1 Life Technologies Company Information
  11.5.2 Life Technologies Companion Diagnostics Product Offered
  11.5.3 Life Technologies Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Life Technologies Main Business Overview
  11.5.5 Life Technologies Latest Developments
11.6 GE Healthcare
  11.6.1 GE Healthcare Company Information
  11.6.2 GE Healthcare Companion Diagnostics Product Offered
  11.6.3 GE Healthcare Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 GE Healthcare Main Business Overview
  11.6.5 GE Healthcare Latest Developments
11.7 Agendia
  11.7.1 Agendia Company Information
  11.7.2 Agendia Companion Diagnostics Product Offered
  11.7.3 Agendia Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Agendia Main Business Overview
  11.7.5 Agendia Latest Developments
11.8 Qiagen
  11.8.1 Qiagen Company Information
  11.8.2 Qiagen Companion Diagnostics Product Offered
  11.8.3 Qiagen Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Qiagen Main Business Overview
  11.8.5 Qiagen Latest Developments
11.9 Genomic Health
  11.9.1 Genomic Health Company Information
  11.9.2 Genomic Health Companion Diagnostics Product Offered
  11.9.3 Genomic Health Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Genomic Health Main Business Overview
  11.9.5 Genomic Health Latest Developments
11.10 Myriad Genetics
  11.10.1 Myriad Genetics Company Information
  11.10.2 Myriad Genetics Companion Diagnostics Product Offered
  11.10.3 Myriad Genetics Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Myriad Genetics Main Business Overview
  11.10.5 Myriad Genetics Latest Developments
11.11 Advanced Cell Diagnostics
  11.11.1 Advanced Cell Diagnostics Company Information
  11.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Offered
  11.11.3 Advanced Cell Diagnostics Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Advanced Cell Diagnostics Main Business Overview
  11.11.5 Advanced Cell Diagnostics Latest Developments
11.12 Danaher
  11.12.1 Danaher Company Information
  11.12.2 Danaher Companion Diagnostics Product Offered
  11.12.3 Danaher Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Danaher Main Business Overview
  11.12.5 Danaher Latest Developments
11.13 Applied Proteomics
  11.13.1 Applied Proteomics Company Information
  11.13.2 Applied Proteomics Companion Diagnostics Product Offered
  11.13.3 Applied Proteomics Companion Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Applied Proteomics Main Business Overview
  11.13.5 Applied Proteomics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Companion Diagnostics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction (PCR)
Table 3. Major Players of Immunohistochemistry (IHC)
Table 4. Major Players of In Situ Hybridization (ISH)
Table 5. Major Players of Next Generation Sequencing (NGS)
Table 6. Companion Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Companion Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Companion Diagnostics Market Size Market Share by Type (2018-2023)
Table 9. Companion Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Companion Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Companion Diagnostics Market Size Market Share by Application (2018-2023)
Table 12. Global Companion Diagnostics Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Companion Diagnostics Revenue Market Share by Player (2018-2023)
Table 14. Companion Diagnostics Key Players Head office and Products Offered
Table 15. Companion Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Companion Diagnostics Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Companion Diagnostics Market Size Market Share by Regions (2018-2023)
Table 20. Global Companion Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Companion Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Companion Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Companion Diagnostics Market Size Market Share by Country (2018-2023)
Table 24. Americas Companion Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Companion Diagnostics Market Size Market Share by Type (2018-2023)
Table 26. Americas Companion Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Companion Diagnostics Market Size Market Share by Application (2018-2023)
Table 28. APAC Companion Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Companion Diagnostics Market Size Market Share by Region (2018-2023)
Table 30. APAC Companion Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Companion Diagnostics Market Size Market Share by Type (2018-2023)
Table 32. APAC Companion Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Companion Diagnostics Market Size Market Share by Application (2018-2023)
Table 34. Europe Companion Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Companion Diagnostics Market Size Market Share by Country (2018-2023)
Table 36. Europe Companion Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Companion Diagnostics Market Size Market Share by Type (2018-2023)
Table 38. Europe Companion Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Companion Diagnostics Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Companion Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Companion Diagnostics Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Companion Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Companion Diagnostics Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Companion Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Companion Diagnostics Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Companion Diagnostics
Table 47. Key Market Challenges & Risks of Companion Diagnostics
Table 48. Key Industry Trends of Companion Diagnostics
Table 49. Global Companion Diagnostics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Companion Diagnostics Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Companion Diagnostics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Companion Diagnostics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Roche Holdings Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 54. Roche Holdings Companion Diagnostics Product Offered
Table 55. Roche Holdings Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Roche Holdings Main Business
Table 57. Roche Holdings Latest Developments
Table 58. Abbott Laboratories Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 59. Abbott Laboratories Companion Diagnostics Product Offered
Table 60. Abbott Laboratories Main Business
Table 61. Abbott Laboratories Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Abbott Laboratories Latest Developments
Table 63. Thermo Fisher Scientific Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 64. Thermo Fisher Scientific Companion Diagnostics Product Offered
Table 65. Thermo Fisher Scientific Main Business
Table 66. Thermo Fisher Scientific Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Thermo Fisher Scientific Latest Developments
Table 68. Agilent Technologies Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 69. Agilent Technologies Companion Diagnostics Product Offered
Table 70. Agilent Technologies Main Business
Table 71. Agilent Technologies Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Agilent Technologies Latest Developments
Table 73. Life Technologies Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 74. Life Technologies Companion Diagnostics Product Offered
Table 75. Life Technologies Main Business
Table 76. Life Technologies Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Life Technologies Latest Developments
Table 78. GE Healthcare Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 79. GE Healthcare Companion Diagnostics Product Offered
Table 80. GE Healthcare Main Business
Table 81. GE Healthcare Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. GE Healthcare Latest Developments
Table 83. Agendia Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 84. Agendia Companion Diagnostics Product Offered
Table 85. Agendia Main Business
Table 86. Agendia Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Agendia Latest Developments
Table 88. Qiagen Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 89. Qiagen Companion Diagnostics Product Offered
Table 90. Qiagen Main Business
Table 91. Qiagen Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Qiagen Latest Developments
Table 93. Genomic Health Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 94. Genomic Health Companion Diagnostics Product Offered
Table 95. Genomic Health Main Business
Table 96. Genomic Health Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Genomic Health Latest Developments
Table 98. Myriad Genetics Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 99. Myriad Genetics Companion Diagnostics Product Offered
Table 100. Myriad Genetics Main Business
Table 101. Myriad Genetics Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Myriad Genetics Latest Developments
Table 103. Advanced Cell Diagnostics Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 104. Advanced Cell Diagnostics Companion Diagnostics Product Offered
Table 105. Advanced Cell Diagnostics Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Advanced Cell Diagnostics Main Business
Table 107. Advanced Cell Diagnostics Latest Developments
Table 108. Danaher Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 109. Danaher Companion Diagnostics Product Offered
Table 110. Danaher Main Business
Table 111. Danaher Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Danaher Latest Developments
Table 113. Applied Proteomics Details, Company Type, Companion Diagnostics Area Served and Its Competitors
Table 114. Applied Proteomics Companion Diagnostics Product Offered
Table 115. Applied Proteomics Main Business
Table 116. Applied Proteomics Companion Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Applied Proteomics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Companion Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Companion Diagnostics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Companion Diagnostics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Companion Diagnostics Sales Market Share by Country/Region (2022)
Figure 8. Companion Diagnostics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Companion Diagnostics Market Size Market Share by Type in 2022
Figure 10. Companion Diagnostics in Hospitals
Figure 11. Global Companion Diagnostics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Companion Diagnostics in Pharmaceutical Companies
Figure 13. Global Companion Diagnostics Market: Pharmaceutical Companies (2018-2023) & ($ Millions)
Figure 14. Companion Diagnostics in Laboratories
Figure 15. Global Companion Diagnostics Market: Laboratories (2018-2023) & ($ Millions)
Figure 16. Companion Diagnostics in Other
Figure 17. Global Companion Diagnostics Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Companion Diagnostics Market Size Market Share by Application in 2022
Figure 19. Global Companion Diagnostics Revenue Market Share by Player in 2022
Figure 20. Global Companion Diagnostics Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Companion Diagnostics Market Size 2018-2023 ($ Millions)
Figure 22. APAC Companion Diagnostics Market Size 2018-2023 ($ Millions)
Figure 23. Europe Companion Diagnostics Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Companion Diagnostics Market Size 2018-2023 ($ Millions)
Figure 25. Americas Companion Diagnostics Value Market Share by Country in 2022
Figure 26. United States Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Companion Diagnostics Market Size Market Share by Region in 2022
Figure 31. APAC Companion Diagnostics Market Size Market Share by Type in 2022
Figure 32. APAC Companion Diagnostics Market Size Market Share by Application in 2022
Figure 33. China Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Companion Diagnostics Market Size Market Share by Country in 2022
Figure 40. Europe Companion Diagnostics Market Size Market Share by Type (2018-2023)
Figure 41. Europe Companion Diagnostics Market Size Market Share by Application (2018-2023)
Figure 42. Germany Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Companion Diagnostics Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Companion Diagnostics Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Companion Diagnostics Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Companion Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 56. APAC Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 57. Europe Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 59. United States Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 60. Canada Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 63. China Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 64. Japan Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 65. Korea Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 67. India Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 68. Australia Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 69. Germany Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 70. France Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 71. UK Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 72. Italy Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 73. Russia Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 74. Spain Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 77. Israel Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Companion Diagnostics Market Size 2024-2029 ($ Millions)
Figure 80. Global Companion Diagnostics Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Companion Diagnostics Market Size Market Share Forecast by Application (2024-2029)